Cryovascular Systems Overview

CryoVascular Systems is a privately held start-up company developing a state-of-the-art therapy for the treatment of coronary and peripheral vascular disease. PolarCath™ is a novel and proprietary new balloon angioplasty device for the treatment of stenotic lesions in the superficial femoral and popliteal arteries resulting from occlusive peripheral vascular disease. It is similar to a...More»

CryoVascular Systems is a privately held start-up company developing a state-of-the-art therapy for the treatment of coronary and peripheral vascular disease. PolarCath™ is a novel and proprietary new balloon angioplasty device for the treatment of stenotic lesions in the superficial femoral and popliteal arteries resulting from occlusive peripheral vascular disease. It is similar to a conventional angioplasty device, but differs in that it utilizes pressurized liquid nitrous oxide to inflate the balloon instead of saline. With conventional balloon angioplasty, a small balloon at the tip of a catheter is placed in a vessel at the site of a blockage. Saline is used to expand the balloon, compressing the plaque that lines the wall of a clogged artery, and opening the vessel for better blood flow. This, in effect, traumatizes the vessel wall, causing scar tissue to form. The liquid nitrous oxide cools the vessel while dilating. Acquired by Boston Scientific.«Less